Kanker-actueel

a

a

a

Sitemap Contact

Seizure Rates in Enzalutamide-Treated Men With Metastatic Castration-Resistant Prostate Cancer and Risk of SeizureThe UPWARD Study

Posted 17/12/2017 11:56:34

17 december 2017: klik op de link voor het artikel en volledige studierapport:

Seizure Rates in Enzalutamide-Treated Men With Metastatic Castration-Resistant Prostate Cancer and Risk of Seizure The UPWARD Study

Susan Slovin, MD, PhD¹; William Clark, MD²; Joan Carles, MD, PhD³; et al Andrew Krivoshik, MD, PhD⁴; Jung Wook Park, PhD⁴; Fong Wang, MD, PhD⁵; Daniel George, MD⁶

...

Lees verder ...

abiraterone acetate, prostaatkanker, AR-V7, resistentie, hormoonresistente prostaatkanker, overall overleving, ziektevrije tijd, Upward study, hartfalen

overall overleving chemo immuuntherapie radiotherapie ziektevrije tijd progressievrije ziekte bestraling anti-PD medicijnen complementair borstkanker longkanker prostaatkanker abiraterone enzalutamide darmkanker